Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder

NCT05849402 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05849402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05849402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 20, 2022
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar ii disorder, most recent episode major depressive, current depressive episode, treatment resistant depression